Changes in serum prolactin after electroconvulsive and epileptic seizures

Area of Science:

• Neuroendocrinology
• Epilepsy Research
• Psychiatric Treatments

Background:

• Serum prolactin (PRL) levels are known to change following certain types of seizures.
• Understanding PRL response can provide insights into seizure pathophysiology and treatment effects.

Purpose of the Study:

• To compare postictal serum prolactin concentrations after epileptic seizures versus electroconvulsive therapy (ECT) seizures.
• To investigate factors influencing prolactin release, including seizure characteristics and medication effects.

Main Methods:

• Serial serum prolactin (PRL) measurements were taken after epileptic and ECT-induced seizures.
• Correlation analysis was performed between seizure duration, seizure type, and PRL levels.
• The impact of chronic dopaminergic medication, including neuroleptics, on PRL secretion was assessed.

Main Results:

• Electroconvulsive therapy (ECT) seizures induced a substantial and rapid increase in serum PRL.
• Spontaneous epileptic seizures showed a more variable PRL response, with longer duration and grand mal seizures yielding higher PRL levels.
• A positive correlation was found between ECT seizure duration and postictal PRL rise.
• Postictal PRL levels over 24 hours were comparable between spontaneous and ECT seizures.
• Neuroleptic medications demonstrated a dose-dependent increase in PRL secretion.

Conclusions:

• Serum prolactin elevation is a consistent marker following ECT seizures, correlating with seizure duration.
• Epileptic seizure-induced prolactin release is more variable but linked to seizure severity and type.
• Dopaminergic agents, particularly neuroleptics, significantly influence prolactin secretion.